Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Valic Co I Health Sciences Fd: (MF: VCHSX)

(MF) As of Sep 15, 2014 06:06 PM ET

 Add to portfolio

$23.33 USD

-0.15 (-0.64%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Aug 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Aug 31, 2014) 19.20
Objective Health Care - Equity
Peer HL MG

Zacks Premium Research for VCHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 30.06
Net Assets (Mil $) 8/31/2014 580.16
%Turnover 8/31/2014 59.00

Allocation

% of Portfolio
Large Growth 76.06
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 8/31/2014 % of Portfolio
Health 44.66
Services 12.33
Finance 10.20
Retail Trade 9.43
Industrial Cyclical 9.41
Other 8.38
Technology 4.68
Non-Durable 0.91

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2014)
% of Portfolio Value (Mil$)
ALEXION PHARMACEUTICALS I 5.15 29.88
GILEAD SCIENCES INC 4.99 28.95
BIOGEN IDEC INC 3.62 20.98
MCKESSON CORP 3.54 20.52
UNITEDHEALTH GROUP INC 3.37 19.55
VALEANT PHARMACEUTICALS 3.35 19.42
AETNA INC 3.25 18.88
ALLERGAN INC 2.98 17.30
AGILENT TECHNOLOGIES INC 2.73 15.85

Stock Holding % of Net Assets

As Of 5/31/2014
Total Issues 143
Avg. P/E 27.03
Avg. P/Book 4.80
Avg. EPS Growth 14.36
Avg. Market Value (Mil $) 33,702

Risk

3 Year 5 Year 10 Year
Beta 0.89 0.93 NA
Alpha 14.85 10.60 NA
R Squared 0.50 0.62 NA
Std. Dev. 14.54 15.59 NA
Sharpe 2.48 1.83 NA